---
figid: PMC9639785__fphar-13-979300-g009
figtitle: Effect of sulfasalazine on endothelium-dependent vascular response by the
  activation of Nrf2 signalling pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9639785
filename: fphar-13-979300-g009.jpg
figlink: /pmc/articles/PMC9639785/figure/F9/
number: F9
caption: Possible pathways of action of sulfasalazine in high glucose. The possible
  pathways of action of sulfasalazine on endothelial dysfunction induced by high glucose.
  AGE, advanced glycation endproduct; RAGE, the receptor for advanced glycation endproduct;
  ROS, reactive oxygen speices; MAPK, the mitogen-activating protein kinase; eNOS,
  endothelial nitric oxide synthase; NO, nitric oxide; ERK, extracellular signal-regulated
  kinase; JNK, Janus kinase family; Nrf2, nuclear factor erythroid 2-related factor
  2; Nf-kB, nuclear factor “kappa-light-chain-enhancer” of activated B-cells; HO-1,
  Heme oxygenase; U0126, ERK inhibitor; SP600125, JNK inhibitor (Prepared on 11.06.2018
  using the website http://www.genome.jp/kegg/pathway.html).
papertitle: Effect of sulfasalazine on endothelium-dependent vascular response by
  the activation of Nrf2 signalling pathway.
reftext: Muhammed Ikbal Sonmez, et al. Front Pharmacol. 2022;13:979300.
year: '2022'
doi: 10.3389/fphar.2022.979300
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: diabetes mellitus | sulfasalazine | Nrf2 | ERK | rat aorta
automl_pathway: 0.9371182
figid_alias: PMC9639785__F9
figtype: Figure
redirect_from: /figures/PMC9639785__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9639785__fphar-13-979300-g009.html
  '@type': Dataset
  description: Possible pathways of action of sulfasalazine in high glucose. The possible
    pathways of action of sulfasalazine on endothelial dysfunction induced by high
    glucose. AGE, advanced glycation endproduct; RAGE, the receptor for advanced glycation
    endproduct; ROS, reactive oxygen speices; MAPK, the mitogen-activating protein
    kinase; eNOS, endothelial nitric oxide synthase; NO, nitric oxide; ERK, extracellular
    signal-regulated kinase; JNK, Janus kinase family; Nrf2, nuclear factor erythroid
    2-related factor 2; Nf-kB, nuclear factor “kappa-light-chain-enhancer” of activated
    B-cells; HO-1, Heme oxygenase; U0126, ERK inhibitor; SP600125, JNK inhibitor (Prepared
    on 11.06.2018 using the website http://www.genome.jp/kegg/pathway.html).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MKP-4
  - p38b
  - rl
  - Erk7
  - l(1)14Ai
  - l(3)65CEc
  - l(2)46Df
  - anon-48Aj
  - anon-XII
  - Keap1
  - cnc
  - Ho
  - tos
  - E(spl)mgamma-HLH
  - bsk
  - Dif
  - dl
  - Rel
  - NOS3
  - ENO4
  - AGER
  - MOK
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - GABPA
  - NFE2L2
  - HMOX1
  - THAS
  - NFKB1
  - glucose
  - Sulfasalazine
---
